SGT-501
SGT-501-101
Phase 1 small_molecule active
Quick answer
SGT-501 for Catecholaminergic Polymorphic Ventricular Tachycardia is a Phase 1 program (small_molecule) at Solid Biosciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Solid Biosciences
- Indication
- Catecholaminergic Polymorphic Ventricular Tachycardia
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active